Juvisync 50 mg / 20 mg Oral Tablet
RxNorm 1312422
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 1312422 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: Juvisync 50 mg / 20 mg Oral Tablet.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
PSN
Prescribable Name (PSN):
Juvisync 50 mg / 20 mg Oral Tablet
(Atom ID: 6363514)
SY
Synonym (SY):
Juvisync 50/20 (sitagliptin 50 mg (sitagliptin phosphate monohydrate 64.25 mg) / simvastatin 20 mg) Oral Tablet
(Atom ID: 4663251)
TMSY
Tall Man Lettering Synonym (TMSY):
Juvisync 50/20 (SITagliptin 50 mg (SITagliptin phosphate monohydrate 64.25 mg) / simvastatin 20 mg) Oral Tablet
(Atom ID: 12428375)
SY
Synonym (SY):
Juvisync 50/20 Oral Tablet
(Atom ID: 4663250)
SBD
Semantic Branded Drug (SBD):
Simvastatin 20 mg / sitagliptin 50 mg Oral Tablet [Juvisync]
(Atom ID: 12360452)
TMSY